BIOXYTRAN, INC (BIXT) Form 10-Q Quarterly Reports
BIOXYTRAN, INC (BIXT) is a publicly traded company on the OTC, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: BIXT
CIK: 1445815
Exchange: OTC
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: NV
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Fruci & Associates II, PLLC
Auditor SinceSince 12/31/2024 12:00:00 AM
Lead Engagement PartnerKemper Rojas
Audit LocationSpokane, Washington, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 10-Q | 2026-08-14 | 2026-06-30 | 10-Q | 0001493152-26-038327 | View SEC Doc Filr Page |
| 8-K | 2026-08-11 | 2026-08-11 | 8-K | 0001493152-26-036977 | View SEC Doc Filr Page |
| 10-Q | 2026-05-15 | 2026-03-31 | 10-Q | 0001493152-26-023538 | View SEC Doc Filr Page |
| 10-K | 2026-04-15 | 2025-12-31 | 10-K | 0001493152-26-016798 | View SEC Doc Filr Page |
| NT 10-K | 2026-04-01 | 2025-12-31 | NT 10-K | 0001493152-26-014474 | View SEC Doc Filr Page |
| 8-K | 2026-03-20 | 2026-03-20 | 8-K | 0001493152-26-011755 | View SEC Doc Filr Page |
| 8-K | 2026-03-13 | 2026-03-12 | 8-K | 0001493152-26-010045 | View SEC Doc Filr Page |
| 8-K | 2026-03-02 | 2026-03-02 | 8-K | 0001493152-26-008475 | View SEC Doc Filr Page |
| 8-K | 2026-02-17 | 2026-02-10 | 8-K | 0001493152-26-006891 | View SEC Doc Filr Page |
| 8-K | 2026-02-11 | 2026-02-11 | 8-K | 0001493152-26-006081 | View SEC Doc Filr Page |
| 8-K | 2026-01-05 | 2025-12-29 | 8-K | 0001493152-26-000418 | View SEC Doc Filr Page |
| 8-K | 2025-12-15 | 2025-12-07 | 8-K | 0001493152-25-027639 | View SEC Doc Filr Page |
| 4 | 2025-11-18 | 2025-08-12 | PRIMARY DOCUMENT | 0001445815-25-000011 | View SEC Doc Filr Page |
| 4 | 2025-11-18 | 2025-08-12 | PRIMARY DOCUMENT | 0001445815-25-000010 | View SEC Doc Filr Page |
| 4 | 2025-11-18 | 2025-08-12 | PRIMARY DOCUMENT | 0001445815-25-000009 | View SEC Doc Filr Page |
| 4 | 2025-11-18 | 2025-11-14 | PRIMARY DOCUMENT | 0001445815-25-000008 | View SEC Doc Filr Page |
| 4/A | 2025-11-18 | 2024-10-24 | PRIMARY DOCUMENT | 0001445815-25-000007 | View SEC Doc Filr Page |
| 4/A | 2025-11-18 | 2024-10-25 | PRIMARY DOCUMENT | 0001445815-25-000006 | View SEC Doc Filr Page |
| 4/A | 2025-11-18 | 2024-10-25 | PRIMARY DOCUMENT | 0001754429-25-000012 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | 10-Q | 0001493152-25-023399 | View SEC Doc Filr Page |
| 10-Q | 2025-08-11 | 2025-06-30 | 10-Q | 0001493152-25-011797 | View SEC Doc Filr Page |
| 10-Q | 2025-05-15 | 2025-03-31 | 10-Q | 0001641172-25-010822 | View SEC Doc Filr Page |
| 10-K | 2025-04-03 | 2024-12-31 | 10-K Filing | 0001641172-25-002614 | View SEC Doc Filr Page |
| 8-K/A | 2025-04-03 | 2024-10-25 | 8-K/A Filing | 0001641172-25-002602 | View SEC Doc Filr Page |
| NT 10-K | 2025-03-31 | 2024-12-31 | NT 10-K Filing | 0001641172-25-001878 | View SEC Doc Filr Page |